Takara spins off biotech unit
Tuesday, 02 April, 2002
Japanese liquor maker Takara Shuzo has stepped up its push to make a name for itself in the biotechnology sector by separating its bio-related activities into a new company.
The split, which was completed on Monday (April 1) as the new Japanese fiscal year began, has resulted in the formation of two companies, Takara Shuzo Co Ltd and Takara Biomedical Co Ltd, under a single holding company, Takara Holdings Inc.
Otsu, Japan based Takara Biomedical includes Dragon Genomics, a genome analysis center formed last year in western Japan.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
